Herein, our study revealed the novel function oflncRP11-675F6.3 and HK1, suggesting a potential lipid regulatory pathway and therapeutic strategy for NAFLD. The gene discussed is HK1; the disease is metabolic dysfunction-associated steatotic liver disease.